{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:48Z","timestamp":1786985088628,"version":"build-2736575974"},"reference-count":93,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008963","name":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.beem.2023.101784","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T12:44:59Z","timestamp":1683722699000},"page":"101784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management of non-hepatic distant metastases in neuroendocrine neoplasms"],"prefix":"10.1016","volume":"37","author":[{"given":"C.","family":"Lacalle-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Estrella Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.C.","family":"Landaeta Kancev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.M.","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Macia Palafox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Paniagua Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Luna Tirado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Mart\u00ednez-Amores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mart\u00ednez Dhier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lamarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF00316983","article-title":"Neuroendocrine metastases of the liver","volume":"19","author":"Ihse","year":"1995","journal-title":"World J Surg"},{"issue":"18","key":"10.1016\/j.beem.2023.101784_bib2","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"issue":"18","key":"10.1016\/j.beem.2023.101784_bib3","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/cncr.28721","article-title":"Gastroenteropancreatic high-grade neuroendocrine carcinoma","volume":"120","author":"Sorbye","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12020-017-1273-x","article-title":"Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms","volume":"58","author":"Leoncini","year":"2017","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.beem.2023.101784_bib5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib6","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1530\/ERC-13-0125","article-title":"Knowledge NETwork. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature","volume":"21","author":"Fraenkel","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000441897","article-title":"Changes in the epidemiology of neuroendocrine tumours","volume":"104","author":"Huguet","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"5","key":"10.1016\/j.beem.2023.101784_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","article-title":"Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting","volume":"30","author":"Reubi","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2967\/jnumed.112.111724","article-title":"Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET\/CT within patients with gastroenteropancreatic neuroendocrine tumors","volume":"54","author":"Wild","year":"2013","journal-title":"J Nucl Med Publ Soc Nucl Med"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2967\/jnumed.106.038653","article-title":"Somatostatin receptor imaging in patients with neuroendocrine tumors: not only SPECT?","volume":"48","author":"Schillaci","year":"2007","journal-title":"J Nucl Med Publ Soc Nucl Med"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib12","article-title":"SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)","volume":"21","author":"GF","year":"2019","journal-title":"Clin Transl Oncol Publ Fed Span Oncol Soc Natl Cancer Inst Mex"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.surg.2021.03.063","article-title":"A prospective study of carcinoid crisis with no perioperative octreotide","volume":"171","author":"Wonn","year":"2022","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib14","first-page":"243","article-title":"Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology","volume":"16","author":"Garc\u00eda-Carbonero","year":"2014","journal-title":"Clin Transl Oncol Publ Fed Span Oncol Soc Natl Cancer Inst Mex"},{"issue":"12","key":"10.1016\/j.beem.2023.101784_bib15","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/ijc.30400","article-title":"The epidemiology of metastases in neuroendocrine tumors","volume":"139","author":"Riihim\u00e4ki","year":"2016","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1677\/ERC-10-0152","article-title":"Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters","volume":"17","author":"Niederle","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib18","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S1470-2045(13)70362-0","article-title":"Recommendations for management of patients with neuroendocrine liver metastases","volume":"15","author":"Frilling","year":"2014","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","article-title":"ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary","volume":"95","author":"Pavel","year":"2012","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/ERC-08-0017","article-title":"Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours","volume":"15","author":"Pape","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.beem.2023.101784_bib21","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/annonc\/mdq022","article-title":"Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE","volume":"21","author":"Garcia-Carbonero","year":"2010","journal-title":"Ann Oncol J Eur Soc Med Oncol"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0039-6257(90)90045-W","article-title":"Tumors metastatic to the orbit: a changing picture","volume":"35","author":"Goldberg","year":"1990","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000287277","article-title":"ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors","volume":"91","author":"Pavel","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EC-14-0119","article-title":"Bone metastases and skeletal-related events from neuroendocrine tumors","volume":"4","author":"Van Loon","year":"2015","journal-title":"Endocr Connect"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000287255","article-title":"ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors","volume":"91","author":"Kos-Kud\u0142a","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101784_bib26","first-page":"94","article-title":"Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysis","author":"Garcia-Torralba","year":"2021","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000151562","article-title":"Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France","volume":"89","author":"Lombard-Bohas","year":"2009","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib28","first-page":"184","article-title":"Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism","volume":"44","author":"Meijer","year":"2003","journal-title":"J Nucl Med Publ Soc Nucl Med"},{"issue":"8","key":"10.1016\/j.beem.2023.101784_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00006231-200208000-00006","article-title":"Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease","volume":"23","author":"Zuetenhorst","year":"2002","journal-title":"Nucl Med Commun"},{"issue":"Suppl 1","key":"10.1016\/j.beem.2023.101784_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000051856","article-title":"Natural history of neuroendocrine enteropancreatic tumors","volume":"62","author":"Mignon","year":"2000","journal-title":"Digestion"},{"issue":"7","key":"10.1016\/j.beem.2023.101784_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1008215730767","article-title":"Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center","volume":"8","author":"Janson","year":"1997","journal-title":"Ann Oncol J Eur Soc Med Oncol"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(85)90313-4","article-title":"The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease","volume":"79","author":"Ross","year":"1985","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.beem.2023.101784_bib33","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2967\/jnumed.108.060236","article-title":"Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy","volume":"50","author":"Putzer","year":"2009","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/B:NEON.0000014517.56866.bc","article-title":"Single brain metastases of carcinoid tumors","volume":"66","author":"Maiuri","year":"2004","journal-title":"J Neurooncol"},{"issue":"11","key":"10.1016\/j.beem.2023.101784_bib35","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/cncr.20659","article-title":"Carcinoid metastasis to the brain","volume":"101","author":"Hlatky","year":"2004","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.beem.2023.101784_bib36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/WNL.36.6.745","article-title":"Neurologic complications of carcinoid","volume":"36","author":"Patchell","year":"1986","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.beem.2023.101784_bib37","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/hupa.2000.19294","article-title":"Pulmonary atypical carcinoid: predictors of survival in 106 cases","volume":"31","author":"Beasley","year":"2000","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1378\/chest.100.4.1053","article-title":"Prognosis of resected well-differentiated neuroendocrine carcinoma of the lung","volume":"100","author":"Lequaglie","year":"1991","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.beem.2023.101784_bib39","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0735-1097(02)02109-5","article-title":"Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients","volume":"40","author":"Pandya","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib40","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.beem.2023.101784_bib41","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1200\/JCO.2000.18.7.1596","article-title":"Case 2: myocardial metastases from a carcinoid tumor","volume":"18","author":"Penz","year":"2000","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"issue":"6","key":"10.1016\/j.beem.2023.101784_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4065\/77.6.591","article-title":"Isolated metastatic myocardial carcinoid tumor in a 48-year-old man","volume":"77","author":"Kasi","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.beem.2023.101784_bib43","first-page":"1528","article-title":"Visualization of myocardial metastasis of carcinoid tumor by indium-111-pentetreotide","volume":"37","author":"Yeung","year":"1996","journal-title":"J Nucl Med Publ Soc Nucl Med"},{"issue":"6","key":"10.1016\/j.beem.2023.101784_bib44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/ceo.13162","article-title":"Metastasis to the extraocular muscles: a case report, literature review and pooled data analysis","volume":"46","author":"Leung","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib45","first-page":"94","article-title":"Orbital metastases from neuroendocrine carcinoma, masquerading as graves orbitopathy","volume":"29","author":"Sira","year":"2010","journal-title":"Orbit Amst Neth"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/09273972.2010.525779","article-title":"Neuroendocrine tumor (carcinoid) metastatic to orbital extraocular muscle: case report and literature review","volume":"18","author":"Matsuo","year":"2010","journal-title":"Strabismus"},{"issue":"11","key":"10.1016\/j.beem.2023.101784_bib47","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/RLU.0000000000002285","article-title":"Incidental orbital neuroendocrine metastases on 111In-OctreoScan and MRI","volume":"43","author":"Chen","year":"2018","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib48","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12020-019-02130-5","article-title":"Orbital metastases from neuroendocrine neoplasms: clinical implications and outcomes","volume":"67","author":"Kamieniarz","year":"2020","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ophtha.2005.10.051","article-title":"Orbital carcinoid metastases","volume":"113","author":"Mehta","year":"2006","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000457954","article-title":"Bone metastases in patients with neuroendocrine neoplasm: frequency and clinical, therapeutic, and prognostic relevance","volume":"106","author":"Scharf","year":"2018","journal-title":"Neuroendocrinology"},{"issue":"7\u20138","key":"10.1016\/j.beem.2023.101784_bib51","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1159\/000504256","article-title":"Identification of areas for improvement in the management of bone metastases in patients with neuroendocrine neoplasms","volume":"110","author":"Lim","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib52","first-page":"121","article-title":"Assessment and clinical implications of RANK\/RANKL\/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases","volume":"18","author":"Milone","year":"2013","journal-title":"Biomark Biochem Indic Expo Response Susceptibility Chem"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib53","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12020-019-01838-8","article-title":"The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice","volume":"64","author":"Alexandraki","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2023.101784_bib54","first-page":"41","article-title":"Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: a multi-institutional registry study with prospective follow-up","volume":"58","author":"H\u00f6rsch","year":"2016","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"5","key":"10.1016\/j.beem.2023.101784_bib55","first-page":"437","article-title":"Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysis","volume":"3","author":"Sabet","year":"2013","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.beem.2023.101784_bib56","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2967\/jnumed.112.102871","article-title":"Tumor response assessment to treatment with [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors: differential response of bone versus soft-tissue lesions","volume":"53","author":"van Vliet","year":"2012","journal-title":"J Nucl Med Publ Soc Nucl Med"},{"issue":"8","key":"10.1016\/j.beem.2023.101784_bib57","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2967\/jnumed.111.090373","article-title":"Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotate","volume":"52","author":"Ezziddin","year":"2011","journal-title":"J Nucl Med Publ Soc Nucl Med"},{"issue":"12","key":"10.1016\/j.beem.2023.101784_bib58","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1200\/JCO.2005.08.066","article-title":"Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors","volume":"23","author":"Kwekkeboom","year":"2005","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.beem.2023.101784_bib59","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S1470-2045(21)00572-6","article-title":"177Lu-Dotatate plus long-acting octreotide versus high\u2011dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial","volume":"22","author":"Strosberg","year":"2021","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib60","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3413\/Nukmed-0614-13-08","article-title":"Can peptide receptor radionuclide therapy be safely applied in florid bone metastases? A pilot analysis of late stage osseous involvement","volume":"53","author":"Sabet","year":"2014","journal-title":"Nukl Nucl Med"},{"issue":"8","key":"10.1016\/j.beem.2023.101784_bib61","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2967\/jnumed.111.090373","article-title":"Response and long-term control of bone metastases after peptide receptor radionuclide therapy with 177Lu-octreotate","volume":"52","author":"Ezziddin","year":"2011","journal-title":"J Nucl Med"},{"issue":"16","key":"10.1016\/j.beem.2023.101784_bib62","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1158\/1078-0432.CCR-16-2743","article-title":"Long-term efficacy, survival, and safety of [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors","volume":"23","author":"Brabander","year":"2017","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"issue":"1091","key":"10.1016\/j.beem.2023.101784_bib63","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180041","article-title":"Retreatment with peptide receptor radionuclide therapy in patients with progressing neuroendocrine tumours: efficacy and prognostic factors for response","volume":"91","author":"Vaughan","year":"2018","journal-title":"Br J Radio"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib64","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/bjc.2013.365","article-title":"Sequelae and survivorship in patients treated with (131)I-MIBG therapy","volume":"109","author":"Sze","year":"2013","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib65","first-page":"177","article-title":"The use of radioisotopes for palliation of metastatic bone pain","volume":"13","author":"Gkialas","year":"2008","journal-title":"J BUON J Balk Union Oncol"},{"issue":"12","key":"10.1016\/j.beem.2023.101784_bib66","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"Bone health in cancer: ESMO clinical practice guidelines\u2020","volume":"31","author":"Coleman","year":"2020","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0269216316639793","article-title":"Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: a systematic review within the European Association for Palliative Care guidelines project","volume":"31","author":"Porta-Sales","year":"2017","journal-title":"Palliat Med"},{"issue":"12","key":"10.1016\/j.beem.2023.101784_bib68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11912-017-0643-0","article-title":"Treatment for malignant pheochromocytomas and paragangliomas: 5 years of progress","volume":"19","author":"Jimenez","year":"2017","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib69","first-page":"1029","article-title":"Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Menshawy","year":"2018","journal-title":"Support Care Cancer J Multinatl Assoc Support Care Cancer"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib70","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbo.2014.11.001","article-title":"Quality of life after palliative radiotherapy in bone metastases: a literature review","volume":"4","author":"McDonald","year":"2015","journal-title":"J Bone Oncol"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib71","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10147-005-0478-9","article-title":"Surgical treatment of bone metastasis: indications and outcomes","volume":"10","author":"Manabe","year":"2005","journal-title":"Int J Clin Oncol"},{"issue":"7","key":"10.1016\/j.beem.2023.101784_bib72","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.3390\/curroncol29070405","article-title":"The management and outcomes of patients with extra-pulmonary neuroendocrine neoplasms and brain metastases","volume":"29","author":"Kapacee","year":"2022","journal-title":"Curr Oncol Tor Ont"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib73","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/neuonc\/now241","article-title":"Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)","volume":"19","author":"Soffietti","year":"2017","journal-title":"Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1021262218151","article-title":"Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease","volume":"61","author":"Pollock","year":"2003","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/nop\/npx009","article-title":"Outcomes of stereotactic radiosurgery of brain metastases from neuroendocrine tumors","volume":"5","author":"Prayongrat","year":"2018","journal-title":"Neuro-Oncol Pr"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib76","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/0284186X.2018.1564841","article-title":"Management of brain metastases from large cell neuroendocrine carcinoma of the lung: improved outcomes with radiosurgery","volume":"58","author":"Wegner","year":"2019","journal-title":"Acta Oncol Stock Swed"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib77","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"10","key":"10.1016\/j.beem.2023.101784_bib78","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1159\/000510444","article-title":"Cardiac metastases in patients with neuroendocrine tumours: clinical features, therapy outcomes, and prognostic implications","volume":"111","author":"Liu","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"13","key":"10.1016\/j.beem.2023.101784_bib79","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1055\/s-0030-1267204","article-title":"A matter of the heart: myocardial metastases in neuroendocrine tumors","volume":"42","author":"Jann","year":"2010","journal-title":"Horm Metab Res Horm Stoffwechs Horm Metab"},{"issue":"7","key":"10.1016\/j.beem.2023.101784_bib80","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jcp.2004.016055","article-title":"Cardiac metastasis from a bronchial carcinoid: report of a case presenting with diffuse thickening of the left ventricular wall","volume":"57","author":"Goddard","year":"2004","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.beem.2023.101784_bib81","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MNM.0000000000000464","article-title":"Cardiac neuroendocrine tumour metastases: case reports and review of the literature","volume":"37","author":"Bonsen","year":"2016","journal-title":"Nucl Med Commun"},{"issue":"6","key":"10.1016\/j.beem.2023.101784_bib82","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0002-9343(99)00250-8","article-title":"Malignant carcinoid tumor with myocardial metastases","volume":"107","author":"Schlegel","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2023.101784_bib83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-0-387-75587-8_7","article-title":"Imaging cardiac tumors","volume":"143","author":"Kalra","year":"2008","journal-title":"Cancer Treat Res"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib84","first-page":"34","article-title":"Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT","volume":"18","author":"Kunz","year":"2018","journal-title":"Cancer Imaging Publ Int Cancer Imaging Soc"},{"issue":"1","key":"10.1016\/j.beem.2023.101784_bib85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1532-429X-10-14","article-title":"Imaging myocardial carcinoid with T2-STIR CMR","volume":"10","author":"Schiavone","year":"2008","journal-title":"J Cardiovasc Magn Reson J Soc Cardiovasc Magn Reson"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib86","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.0004-8461.2004.01323.x","article-title":"Cardiac metastasis from carcinoid tumour: magnetic resonance imaging findings","volume":"48","author":"Puvaneswary","year":"2004","journal-title":"Austral Radio"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib87","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2214\/ajr.152.3.469","article-title":"Cardiac masses: assessment by MR imaging","volume":"152","author":"Lund","year":"1989","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.beem.2023.101784_bib88","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1752-1947-1-95","article-title":"External beam irradiation of myocardial carcinoid metastases: a case report","volume":"1","author":"Strosberg","year":"2007","journal-title":"J Med Case Rep"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib89","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/1097-0142(197609)38:3<1326::AID-CNCR2820380336>3.0.CO;2-#","article-title":"Carcinoma metastatic to the eye and orbit III. A clinicopathologic study of 28 cases metastatic to the orbit","volume":"38","author":"Font","year":"1976","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.beem.2023.101784_bib90","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0974-620X.91268","article-title":"A case series of neuroendocrine (carcinoid) tumor metastasis to the orbit","volume":"4","author":"Turaka","year":"2011","journal-title":"Oman J Ophthalmol"},{"issue":"4","key":"10.1016\/j.beem.2023.101784_bib91","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1210\/jcem.87.4.8407","article-title":"Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide","volume":"87","author":"Isidori","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3 Suppl","key":"10.1016\/j.beem.2023.101784_bib92","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","article-title":"Radiation dose-volume effects in the brain","volume":"76","author":"Lawrence","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.beem.2023.101784_bib93","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejrad.2015.11.041","article-title":"Characterization of orbital masses by multiparametric MRI","volume":"85","author":"Ro","year":"2016","journal-title":"Eur J Radio"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:59:21Z","timestamp":1761497961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X23000581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":93,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1521690X23000581"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2023.101784","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of non-hepatic distant metastases in neuroendocrine neoplasms","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2023.101784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101784"}}